纤维蛋白溶解与凝血抑制的病理生理学及临床方面。特别针对口服避孕药的女性和特定血栓易患人群的实验与临床研究。
Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
作者信息
Jespersen J
机构信息
Department of Clinical Chemistry, Ribe County Hospital, Esbjerg, Denmark.
出版信息
Dan Med Bull. 1988 Feb;35(1):1-33.
The primary aim of the haemostatic mechanism is to protect the vascular system and to keep it intact after injury in order to secure the function of tissues and organs. A second aim is to provide a matrix in wound healing and tissue repair. The regulation of this physiological mechanism is effected by a dynamic haemostatic balance comprising interactions between endothelial cells, thrombocytes, coagulation, and fibrinolysis. This balance determines the amount of fibrin layed down at a site of injury thereby influencing the progress of the reparative processes. Clinical experience has, as described, shown that the concept of a dynamic haemostatic balance, and the increase in knowledge about the mechanisms involved in its regulation, can be applied with success in the elucidation and treatment of cases of impaired haemostasis, or when during a disease instances of thrombosis or embolism arise, which otherwise would have been difficult to explain or to subject to rational treatment. The results obtained and the experiences gained have therefore substantiated the existence of such a balance. Disturbances in the regulation of the balance may cause the formation and deposition of too little fibrin at a site of injury resulting in impaired haemostasis, ultimately manifesting itself as a haemorrhagic disorder. Or, an enhanced formation or delayed resolution of fibrin may cause thrombosis. Therefore, in the acute clinical cases the balance may adequately be described as a thrombohaemorrhagic balance. These observations have in particular underscored the role of an impaired fibrinolysis or decreased inhibition of coagulation in the pathogenesis of thromboembolic disease. They suggest the existence of an antithrombotic potential, which might be reduced due to a decreased inhibition of coagulation and/or a decreased fibrinolysis. The major stages in the mechanisms of blood coagulation and fibrin resolution are now well elucidated. This has increased our understanding of the interplay between the activating and regulating factors by which the organism keeps the formation of fibrin under control. Effects of disturbances in the balance are illustrated by description of cases of haemorrhagic disorders or thrombosis, and the pathophysiological aspects are surveyed. The regulation of coagulation and fibrinolysis follows in both systems the same pattern. The active enzymes (thrombin and plasmin, respectively) are formed by activation of circulating proenzymes, and inhibitors (circulating or localized) exert their modifying influences at various stages of the total process.(ABSTRACT TRUNCATED AT 400 WORDS)
止血机制的主要目的是保护血管系统,并在受伤后使其保持完整,以确保组织和器官的功能。第二个目的是在伤口愈合和组织修复过程中提供一个基质。这种生理机制的调节是通过一种动态止血平衡来实现的,该平衡包括内皮细胞、血小板、凝血和纤溶之间的相互作用。这种平衡决定了在损伤部位沉积的纤维蛋白量,从而影响修复过程的进展。如前所述,临床经验表明,动态止血平衡的概念以及对其调节机制的认识的增加,可以成功地应用于阐明和治疗止血功能受损的病例,或者在疾病过程中出现血栓形成或栓塞的情况时,否则这些情况将难以解释或进行合理治疗。因此,所获得的结果和经验证实了这种平衡的存在。平衡调节的紊乱可能导致损伤部位纤维蛋白形成和沉积过少,从而导致止血功能受损,最终表现为出血性疾病。或者,纤维蛋白形成增加或溶解延迟可能导致血栓形成。因此,在急性临床病例中,这种平衡可以恰当地描述为血栓-出血平衡。这些观察结果特别强调了纤溶受损或凝血抑制降低在血栓栓塞性疾病发病机制中的作用。它们表明存在一种抗血栓形成潜力,这种潜力可能由于凝血抑制降低和/或纤溶降低而降低。目前,血液凝固和纤维蛋白溶解机制的主要阶段已得到充分阐明。这增加了我们对机体控制纤维蛋白形成的激活和调节因子之间相互作用的理解。通过描述出血性疾病或血栓形成的病例来说明平衡紊乱的影响,并对病理生理学方面进行了综述。凝血和纤溶的调节在两个系统中遵循相同的模式。活性酶(分别为凝血酶和纤溶酶)是通过循环前体酶的激活形成 的,抑制剂(循环或局部)在整个过程的不同阶段发挥其调节作用。(摘要截断于400字)